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Abstract:
Object
Despite advances in microsurgical techniques, complete surgical resection of large acoustic neuroma is still associated 
with significant morbidity related to facial palsy. By modifying the techniques of microsurgery and combined it with 
planned post-operative radiosurgery, the authors aimed to reduce the incidence of permanent facial nerve palsy to 
near zero in a prospective study.
Methods
Between 2000 and 2011, 54 large (Koo’s classification stage 4) acoustic neuromas (AN), were managed by the senior 
authors with planned microsurgery (MS) followed by Gamma Knife surgery (GKS). Mean tumor volume before MS 
was 17.6 cc (4.9 - 44.5). Mean follow up time was 70 months with minimum 3 years follow up. The authors adhered 
to a strict surgical protocol: 1. Debulk brain stem side of the tumor until the root entry zone of the trigeminal nerve 
and the white surface of the pons were visualized. 2. Leave a safe cushion of tumor capsule along the facial nerve that 
was mapped according to intra-operative EMG monitoring. 3. Internal acoustic meatus was not opened. Between 3 
to 6 months after MS, all patients underwent GKS, which was also performed by the same surgeon. Typically 12Gy 
at 40-50% isodose line was delivered to margin of residual tumour. All patients underwent yearly sequential MRI to 
assess tumor volume control.
Results
There was no operative mortality for all 54 patients. Two (3.7%) patients had transient facial weakness, which 
recovered completely within 3 months. None (0%) suffered from permanent facial palsy. None had other additional 
cranial neuropathy or added deficits. One patient had a transient CSF leak that required no additional procedure. 
Mean postoperative tumor volume was 3.8 cc (0.37 -15.7). Mean tumor volume reduction by MS was 78.4%. Mean 
tumor volume at 3 years after GKS was 2.8 cc (0.17 - 10.4), a 47% reduction. Mean total reduction tumor volume for 
combined MS and GKS was 84%. No patient had regrowth of the tumour during the follow-up period.
Conclusions
The authors believed selective brain stem side debulking, facial nerve preservation strategy and de-vascularization 
of large ANs facilitated growth control by planned GKS. The results of near zero facial nerve palsy compared favorably 
with the best published results in terms of functional preservation of facial nerve and eventual shrinkage of the 
tumor.
